A new study finds that inherited genetic variation plays a role in who is likely to benefit from checkpoint inhibitors, which release the immune system’s brakes so it can attack cancer.
UCSF researchers found that mice in which activity of a protein called eIF4E is diminished, either genetically or pharmaceutically, gain only half the weight of other mice, even if all the mice eat a high-fat diet.
Many cancer patients might respond better to treatments with the help of a new prognostic indicator based on a distinctive pattern of gene activity within tumor cells.
The UC Riverside School of Medicine's Department of Psychiatry and Neuroscience will launch a unique, first-in-the-nation sports psychiatry fellowship program. Developed in partnership with UC Riverside Intercollegiate Athletics and UCR Health, this non-ACGME program will begin accepting applications in 2021 and will start in 2022.
Susan Acton discovered ACE2 while searching for new cardiovascular drugs. Decades later, she was surprised to see it popping up in the news once COVID took hold.
Health Media Contacts
Find the best contact for health-related media inquiries.
